ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Drug Development Budget Cuts Force Early End To P388 Screening Contracts

January 9, 1987

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988

NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions

October 16, 2009

Scrutiny of caBIG Exposes Conflicts, Bonanza For Contractors

March 18, 2011

Ganz Awarded Professor Of Survivorship By Komen.

January 28, 2000

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

April 26, 2013